ThromboGenics

Views:
 
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

PowerPoint Presentation:

Emilie Stockman 2FI03 4/1/2014 1

Summary:

Summary Evolution BEL20 Conclusion Expectation 4/1/2014 2

Evolution:

Evolution 4/1/2014 3 7 aug 4.64

Evolution:

Evolution 4/1/2014 4 7 17

Evolution:

Evolution 4/1/2014 5 35

BEL20:

BEL20 4/1/2014 6

Conclusion:

Conclusion Unexpected sale 4/1/2014 7

Expectation:

Expectation Gain Marketing Transferee € 26.00 per share 4/1/2014 8

Sources:

Sources http:// www.tijd.be/beurzen/ThromboGenics.60191463 http://www.thrombogenics.com / http://www.standaard.be/cnt/dmf20140224_00995835 4/1/2014 9

Thank you for your attention!:

4/1/2014 10 Thank you for your attention !

authorStream Live Help